Modifying Physical Activity Patterns in Individuals with Inflammatory Arthritis: A Comprehensive Review of Current Practices, Influencing Factors, and Intervention Strategies - Top-Institutions - MDSpire

Modifying Physical Activity Patterns in Individuals with Inflammatory Arthritis: A Comprehensive Review of Current Practices, Influencing Factors, and Intervention Strategies

  • By

  • Manuel Ester

  • Daniel Gillespie

  • Saania Zafar

  • Racheal Githumbi

  • Kiran Dhiman

  • Kamala Adhikari

  • Claire Barber

  • December 3, 2025

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    University of Toronto
    University of Toronto

    Toronto, ON

    Key Differentiators

    • Rheumatology
    • Physical Therapy
    • Behavioral Medicine

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Rehabilitation Medicine
    • Epidemiology

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Rheumatology
    • Physical Medicine and Rehabilitation
    • Public Health

  • #4

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Stockholm County

    Key Differentiators

    • Rheumatology
    • Rehabilitation
    • Epidemiology

  • #5

    University of Manchester
    University of Manchester

    Manchester, England

    Key Differentiators

    • Rheumatology
    • Physiotherapy
    • Behavioral Science

Original Source(s)

Modifying Physical Activity Patterns in Individuals with Inflammatory Arthritis: A Comprehensive Review of Current Practices, Influencing Factors, and Intervention Strategies

  • by Manuel Ester, Daniel Gillespie, Saania Zafar, Racheal Githumbi, Kiran Dhiman, Kamala Adhikari, Claire Barber

  • December 3, 2025

Related Content

Neutrophil extracellular traps and pyroptosis: a molecular nexus linking systemic autoimmune diseases to atherosclerosis

Can Shorter TB Prevention Regimens Work?

Randomized study evaluates efficacy, safety, and completion in high-risk patients

FDA Expands Guselkumab Label in PsA

Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.